Rockwell Medical updates its 2026 annual guidance as follows:
| 2026 Annual Guidance | |
| Net Sales | $70.0M to $75.0M |
| Gross Margin | 18% to 22% |
| Adjusted EBITDA | $1.0M to $2.0M |
| Operating Cash Flow | Positive |
Rockwell Medical updates its 2026 annual guidance as follows:
| 2026 Annual Guidance | |
| Net Sales | $70.0M to $75.0M |
| Gross Margin | 18% to 22% |
| Adjusted EBITDA | $1.0M to $2.0M |
| Operating Cash Flow | Positive |
Login to comment